Amplitudes of pain-related evoked potentials are useful to detect small fiber involvement in painful mixed fiber neuropathies in addition to quantitative sensory testing - An electrophysiological study

Frontiers in Neurology

Volumn 6, Issue DEC, 2015, Pages

  Hansen, Niels ^a,b,c   Kahn, Ann Kathrin ^a   Zeller, Daniel ^a   Katsarava, Zaza ^d   Sommer, Claudia ^a   Üçeyler, Nurcan ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d EVANGELISCHES KRANKENHAUS   (Germany)

Author keywords

Ad and C fibers; Burning pain; Mixed fiber neuropathy; Neuropathic pain; Pain related evoked potentials; Quantitative sensory testing

Indexed keywords

ADULT; AGED; AMPLITUDE MODULATION; ARTICLE; BURNING SENSATION; CLINICAL ARTICLE; COLD PAIN THRESHOLD; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DYSESTHESIA; ELECTRIC CONDUCTIVITY; EVOKED RESPONSE; FEMALE; HEAT PAIN THRESHOLD; HUMAN; HUMAN TISSUE; MALE; MIXED FIBER NEUROPATHY; NERVE CONDUCTION VELOCITY; NEUROPATHY; PAIN INTENSITY; PAIN RELATED EVOKED POTENTIAL; PAIN THRESHOLD; PUNCH BIOPSY; QUANTITATIVE SENSORY TESTING; SENSORY SYSTEM ELECTROPHYSIOLOGY; SENSORY SYSTEM EXAMINATION; SKIN BIOPSY; SMALL FIBER NEUROPATHY; SURAL NERVE; VERY ELDERLY; VIBRATION SENSE;

EID: 84955138498     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2015.00244     Document Type: Article

References (62)

1. Singleton JR, Smith AG, Bromberg MB. Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve (2001) 24:1225-8. doi:10.1002/mus.1136
2. Hoejmakers JG, Faber CG, Lauria G, Merkies IS, Waxman SG. Small-fibre neuropathies-advances in diagnosis, pathophysiology and management. Nat Rev Neurol (2012) 29:369-79. doi:10.1038/nrneurol.2012.97
3. González-Duarte A, Lem-Carrillo M, Cárdenas-Soto K. Description of transthyretin S50A, S52P and G47A mutations in familial amyloidosis polyneuropathy. Amyloid (2013) 20:221-5. doi:10.3109/13506129.2013.827110
4. Zara G, Zambello R, Ermani M. Neurophysiological and clinical responses to rituximab in patients with anti-MAG polyneuropathy. Clin Neurophysiol (2011) 122:2518-22. doi:10.1016/j.clinph.2011.05.015
5. Van den Bergh P, Hadden RD, Bouche P, Cornblath DR, Hahn A, Illa I, et al. European federation of neurological societies/peripheral nerve society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European federation of neurological societies and the peripheral nerve society - first revision. Eur J Neurol (2010) 17:356-63. doi:10.1111/j.1468-1331.2009.02930.x
6. Cruccu G, Sommer C, Anand P, Attal N, Baron R, Garcia-Larrea L. EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol (2010) 17:1010-8. doi:10.1111/j.1468-1331.2010.02969.x
7. Casanova-Molla J, Grau-Junyent JM, Morales M, Valls-Solé J. On the relationship between nociceptive evoked potentials and intraepidermal nerve fiber density in painful sensory polyneuropathies. Pain (2011) 152:410-8. doi:10.1016/j.pain.2010.11.012
8. Treede RD, Lorenz J, Baumgärtner U. Clinical usefulness of laser-evoked potentials. Neurophysiol Clin (2003) 33:303-14. doi:10.1016/j.neucli.2003.10.009
9. Kaube H, Katsarava Z, Käufer T, Diener H, Ellrich J. A new method to increase nociception specificity of the human blink reflex. Clin Neurophysiol (2000) 111:413-6. doi:10.1016/S1388-2457(99)00295-3
10. Mueller D, Obermann M, Koeppen S, Kavuk I, Yoon MS, Sack F. Electrically evoked nociceptive potentials for early detection of diabetic small-fiber neuropathy. Eur J Neurol (2010) 17:834-41. doi:10.1111/j.1468-1331.2009.02938.x
11. Obermann M, Katsarava Z, Esser S, Sommer C, He L, Selter L, et al. Correlation of epidermal nerve fiber density with pain-related evoked potentials in HIV neuropathy. Pain (2008) 138:79-86. doi:10.1016/j.pain.2007.11.009
12. üçeyler N, Kahn AK, Kramer D, Zeller D, Casanova-Molla J, Wanner C, et al. Impaired small fiber conduction in patients with Fabry disease: a neurophysiological case-control study. BMC Neurol (2013) 13:47. doi:10.1186/1471-2377-13-47
13. Üçeyler N, Zeller D, Kahn AK, Kewenig S, Kittel-Schneider S, Schmid A, et al. Small fibre pathology in patients with fibromyalgia syndrome. Brain (2013) 136:1857-67. doi:10.1093/brain/awt053
14. Yoon MS, Obermann M, Dockweiler C, Assert R, Canbay A, Haag S. Sensory neuropathy in patients with cryoglobulin negative hepatitis-C infection. J Neurol (2011) 258:80-8. doi:10.1007/s00415-010-5686-1
15. Chiang MC, Lin YH, Pan CL, Tseng TJ, Lin WM, Hsieh ST. Cutaneous innervation in chronic inflammatory demyelinating polyneuropathy. Neurology (2002) 59:1094-8. doi:10.1212/WNL.59.7.1094
16. Martinez V, Fletcher D, Martin F, Orlikowski D, Sharshar T, Chauvin M, et al. Small fibre impairment predicts neuropathic pain in Guillain-Barré syndrome. Pain (2010) 151:53-60. doi:10.1016/j.pain.2010.05.017
17. Ruts L, van Doorn PA, Lombardi R, Haasdijk ED, Penza P. Unmyelinated and myelinated skin nerve damage in Guillain-Barré syndrome: correlation with pain and recovery. Pain (2012) 153:399-409. doi:10.1016/j.pain.2011.10.037
18. Dyck PJ, Sherman WR, Hallcher LM, Service FJ, O'Brien PC, Grina LA, et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol (1980) 8:590-6. doi:10.1002/ana.410080608
19. Young MJ, Boulton AJM, Macleod AF, Williams DRR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia (1993) 36:150-4. doi:10.1007/BF00400697
20. Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E. Development and validation of the neuropathic pain symptom inventory. Pain (2004) 108:248-57. doi:10.1016/j.pain.2003.12.024
21. Sommer C, Richter H, Rogausch JP, Frettlöh J, Lungenhausen M, Maier C. A modified score to identify and discriminate neuropathic pain: a study on the German version of the neuropathic pain symptom inventory (NPSI). BMC Neurol (2011) 11:104. doi:10.1186/1471-2377-11-104
22. Stein C, Mendl G. The German counterpart to McGill pain questionnaire. Pain (1998) 32:251-5. doi:10.1016/0304-3959(88)90074-7
23. Beissner F, Brandau A, Henke C, Felden L, Baumgärtner U, Treede RD, et al. Quick discrimination of A(delta) and C fiber mediated pain based on three verbal descriptors. PLoS One (2010) 5:e12944. doi:10.1371/journal.pone.0012944
24. Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain (1992) 50:133-49. doi:10.1016/0304-3959(92)90154-4
25. Radloff LS. The CES-D: a self report symptom scale to detect depression in the general population. Appl Psychol Meas (1977) 3:385-401.
26. Hughes R, Bensa S, Willison H, Van den Bergh P, Comi G, Illa I, et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol (2001) 50:195-201. doi:10.1002/ana.1088
27. Collins MP, Dyck PJ, Gronseth GS, Guillevin L, Hadden RD, Heuss D, et al. Peripheral nerve society guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary. J Peripher Nerv Syst (2010) 15:176-84. doi:10.1111/j.1529-8027.2010.00281.x
28. Rolke R, Baron R, Maier C, Tölle TR, Treede RD, Beyer A, et al. Quantitative sensory testing in the German research network on neuropathic pain (DFNS): standardized protocol and reference values. Pain (2006) 123:231-43. doi:10.1016/j.pain.2006.01.041
29. Rolke R, Magerl W, Campbell KA, Schalber C, Caspari S, Birklein F, et al. Quantitative sensory testing: a comprehensive protocol for clinical trials. Eur J Pain (2006) 10:77-88. doi:10.1016/j.ejpain.2005.02.003
30. Magerl W, Krumova EK, Baron R, Tölle T, Treede RD, Maier C. Reference data for quantitative sensory testing (QST): refined stratification for age and a novel method for statistical comparison of group data. Pain (2010) 151:598-605. doi:10.1016/j.pain.2010.07.026
31. Mücke M, Cuhls H, Radbruch L, Baron R, Maier C, Tölle T, et al. [Quantitative sensory testing]. Schmerz (2014) 28:635-48. doi:10.1007/s00482-014-1485-4
32. Olson CL. On choosing a test statistic in multivariate analysis of variance. Psychol Bull (1976) 83:579-86. doi:10.1037/0033-2909.83.4.579
33. Magerl W, Wilk SH, Treede RD. Secondary hyperalgesia and perceptual wind-up following intradermal injection of capsaicin in humans. Pain (1998) 74:257-68. doi:10.1016/S0304-3959(97)00177-2
34. Treede RD, Baron R. How to detect a sensory abnormality. Eur J Pain (2008) 12:395-6. doi:10.1016/j.ejpain.2007.11.008
35. Maier C, Baron R, Tölle TR, Binder A, Birbaumer N, Birklein F. Quantitative sensory testing in the German research network on neuropathic pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. Pain (2010) 150:439-50. doi:10.1016/j.pain.2010.05.002
36. Westermann A, Rönnau AK, Krumova E, Regeniter S, Schwenkreis P, Rolke R, et al. Pain-associated mild sensory deficits without hyperalgesia in chronic non-neuropathic pain. Clin J Pain (2011) 27:782-9. doi:10.1097/AJP.0b013e31821d8fce
37. Kimura J. Electrodiagnosis in Diseases of Nerve and Muscle: Principles and Practice. New York, NY: Oxford University Press (2001).
38. Üçeyler N, Kafke W, Riediger N, He L, Necula G, Toyka KV. Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy. Neurology (2010) 74:1806-13. doi:10.1212/WNL.0b013e3181e0f7b3
39. Lauria G, Cornblath DR, Johansson O, McArthur JC, Mellgren SI, Nolano M, et al. EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol (2005) 12:747-58. doi:10.1111/j.1468-1331.2005.01260.x
40. Pazzaglia C, Vollono C, Ferraro D, Virdis D, Lupi V, Le Pera D. Mechanisms of neuropathic pain in patients with Charcot-Marie-Tooth 1 A: a laser-evoked potential study. Pain (2010) 149:379-85. doi:10.1016/j.pain.2010.03.001
41. Barraza-Sandoval G, Casanova-Mollá J, Valls-Solé J. Neurophysiological assessment of painful neuropathies. Expert Rev Neurother (2012) 12:1297-309. doi:10.1586/ern.12.93
42. Bragard D, Chen AC, Plaghki L. Direct isolation of ultra-late (C-fibre) evoked brain potentials by CO2 laser stimulation of tiny cutaneous surface areas in man. Neurosci Lett (1996) 209:81-4. doi:10.1016/0304-3940(96)12604-5
43. Magerl W, Ali Z, Ellrich J, Meyer RA, Treede RD. C-and A delta-fiber components of heat-evoked cerebral potentials in healthy human subjects. Pain (1999) 82:127-37. doi:10.1016/S0304-3959(99)00061-5
44. Iannetti GD, Baumgärtner U, Tracey I, Treede RD, Magerl W. Pinprick-evoked brain potentials: a novel tool to assess central sensitization of nociceptive pathways in humans. J Neurophysiol (2013) 110:1107-16. doi:10.1152/jn.00774.2012
45. Kakigi R, Endo C, Neshige R, Kuroda Y, Shibasaki H. Estimation of conduction velocity of A delta fibers in humans. Muscle Nerve (1991) 14:1193-6. doi:10.1002/mus.880141209
46. Lefaucheur JP, Ahdab R, Ayache SS, Lefaucheur-Ménard I, Rouie D, Tebbal D. Pain-related evoked potentials: a comparative study between electrical stimulation using a concentric planar electrode and laser stimulation using a CO2 laser. Neurophysiol Clin (2012) 42:199-206. doi:10.1016/j.neucli.2011.12.003
47. Katsarava Z, Ayzenberg I, Sack F, Limmroth V, Diener HC, Kaube H. A novel method of eliciting pain-related potentials by transcutaneous electrical stimulation. Headache (2006) 46:1511-7. doi:10.1111/j.1526-4610.2006.00446.x
48. de Tommaso M, Santostasi R, Devitofrancesco V, Franco G, Vecchio E, Delussi M, et al. A comparative study of cortical responses evoked by transcutaneous electrical vs CO(2) laser stimulation. Clin Neurophysiol (2011) 122:2482-7. doi:10.1016/j.clinph.2011.05.006
49. Perchet C, Frot M, Charmarty A, Flores C, Mazza S, Magnin M, et al. Do we activate specifically somatosensory thin fibres with the concentric planar electrode? A scalp and intracranial EEG-study. Pain (2012) 153:1244-52. doi:10.1016/j.pain.2012.03.004
50. Bromm B, Treede RD. Laser-evoked cerebral potentials in the assessment of cutaneous pain sensitivity in normal subjects and patients. Rev Neurol (Paris) (1991) 10:625-43.
51. Cruccu G, Pennisi E, Truini A, Iannetti GD, Romaniello A, Le Pera D, et al. Unmyelinated trigeminal pathways as assessed by laser stimuli in humans. Brain (2003) 126:2246-56. doi:10.1093/brain/awg227
52. Tanabe M, Murakami H, Honda M, Ono H. Gabapentin depresses C-fiber-evoked field potentials in rat spinal dorsal horn only after induction of long-term potentiation. Exp Neurol (2006) 202:280-6. doi:10.1016/j.expneurol.2006.06.002
53. Hendrich J, Bauer CS, Dolphin AC. Chronic pregabalin inhibits synaptic transmission between rat dorsal root ganglion and dorsal horn neurons in culture. Channels (2012) 6:124-32. doi:10.4161/chan.19805
54. Rohdewald P, Derendorf H, Drehsen G, Elger CE, Knoll O. Changes in cortical evoked potentials as correlates of the efficacy of weak analgesics. Pain (1982) 12:329-41. doi:10.1016/0304-3959(82)90178-6
55. Jimenez-Cohl P, Grekin C, Leyton C, Vargas C, Villaseca R. Thermal threshold: research study on small fiber dysfunction in distal diabetic polyneuropathy. J Diabetes Sci Technol (2012) 6:177-83. doi:10.1177/193229681200600122
56. Krøigård T, Schrøder HD, Qvortrup C, Eckhoff L, Pfeiffer P, Gaist D. Characterization and diagnostic evaluation of chronic polyneuropathies induced by oxaliplatin and docetaxel comparing skin biopsy to quantitative sensory testing and nerve conduction studies. Eur J Neurol (2014) 21:623-9. doi:10.1111/ene.12353
57. Serra J, Solà R, Aleu J, Quiles C, Navarro X, Bostock H. Double and triple spikes in C-nociceptors in neuropathic pain states: an additional peripheral mechanism of hyperalgesia. Pain (2011) 152:343-53. doi:10.1016/j.pain.2010.10.039
58. Serra J, Bostock H, Solà R, Aleu J, Garcia E, Cokic B. Microneurographic identification of spontaneous activity in C-nociceptors in neuropathic pain states in humans and rats. Pain (2012) 153:42-55. doi:10.1016/j.pain.2011.08.015
59. Kleggetveit IP, Namer B, Schmidt R, Helås T, Rückel M, Ørstavik K, et al. High spontaneous activity of C-nociceptors in painful polyneuropathy. Pain (2012) 153:2040-7. doi:10.1016/j.pain.2012.05.017
60. Truini A, Biasiotta A, La Cesa S, Di Stefano G, Galeotti F, Petrucci MT, et al. Mechanism of pain in distal symmetric polyneuropathy: a combined clinical and neurophysiological study. Pain (2010) 150:516-21. doi:10.1016/j.pain.2010.06.006
61. Otto M, Bak S, Bach FW, Jensen TS, Sindrup SH. Pain phenomena and possible mechanisms in patients with painful neuropathy. Pain (2003) 10:187-92. doi:10.1016/S0304-3959(02)00313-5
62. Torebjörk HE, Ochoa JL. Specific sensations evoked by activity single identified sensory units in man. Acta Physiol Scand (1980) 110:445-7. doi:10.1111/j.1748-1716.1980.tb06695.x